Michael J. Abrams serves as Executive at Arbutus Biopharma Corp, where they oversee executive responsibilities. Since joining the company, Michael J. Abrams has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Aug 16, 2016 involved exercising options for 14,178 shares valued at $5.0K.
Michael J. Abrams currently holds 42,097 shares of Arbutus Biopharma Corp (TKMR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael J. Abrams has been a net neutral trader of TKMR stock. They have purchased $0 and sold $0 worth of shares.
Michael J. Abrams's most recent insider trade was on Aug 16, 2016, when they sold 14,178 shares at $0.35 per share.
Get notified when new Form 4 filings are submitted
| 17,044 |
| $0.44 |
| Discretionary |